Newer Anti-CD20 Drug Prevails in Follicular Lymphoma (CME/CE)

(MedPage Today) -- Better PFS with obinutuzumab but with more adverse events
Source: MedPage Today Meeting Coverage - Category: Journals (General) Source Type: news